SB
SUTOL Bio has developed a monthly oral capsule that delivers continuous drug release for chronic conditions, eliminating the need for daily pills or injectable therapies. The platform provides a pharmacy‑dispensed, patient‑friendly solution with 30+ days of sustained release, improving adherence and reducing clinic visits. Revenue is generated through pharmaceutical partnerships and sales of the capsule to healthcare providers and insurers.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- SUTOL Bio develops a monthly oral capsule platform designed to transform the treatment of chronic conditions. This drug delivery system provides 30+ days of continuous release through a single, patient-friendly oral dose. The solution eliminates the adherence challenges of daily pills and the inconvenience of painful, clinic-administered injections.